Inactive Instrument

Health Sciences Group, Inc. Stock Other OTC

Equities

HESG

US42223A1007

Biotechnology & Medical Research

Sales 2004 3.26 Sales 2005 0.06 Capitalization 10.25M
Net income 2004 -10M Net income 2005 -5M EV / Sales 2004 3,698,627 x
Net Debt 2004 640K Net Debt 2005 314K EV / Sales 2005 175,645,572 x
P/E ratio 2004
-0.9 x
P/E ratio 2005
-1.57 x
Employees -
Yield 2004 *
-
Yield 2005
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
President - 96-06-12
Members of the board TitleAgeSince
President - 96-06-12
More insiders
Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.
More about the company